Geneva, May 8 (UNI) The World Health Organization (WHO) has validated the COVID-19 vaccine developed by China's Sinopharm for emergency use, a move set to boost global vaccine rollout, particularly in the developing world.
"This afternoon, the WHO gave emergency use listing to Sinopharm Beijing's COVID-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality," said WHO Director-General Dr Tedros Adhanom Ghebreyesus at a press briefing on Friday.
China's premier news agency reported that the jab is an inactivated vaccine with easy storage requirements, which makes it highly suitable for use in low-resource settings.